Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
PHASE3
Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone...
Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
PHASE1
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis
PHASE1
Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
PHASE1
There are 5 parts to this study for which the primary objectives are to eva...